Akili Interactive Labs Inc., has expanded its series B financing with an additional $11.9m from new investors Merck Ventures BV, Amsterdam, The Netherlands, a subsidiary of Merck KGAA, and Amgen Ventures, the venture arm of Amgen Inc.
Earlier this year, Akili raised $30.5m from investors including JAZZ Venture Partners, Canepa Advanced Healthcare Fund and PureTech totaling the...




![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
